Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 322,073 | 63,209 | 91,689 | 79,256 | 130,014 |
| Cost of Goods | 3,231 | 2,491 | 1,899 | N/A | N/A |
| Gross Profit | 318,842 | 60,718 | 89,790 | 79,256 | 130,014 |
| Operating Expenses | 177,628 | 164,488 | 221,313 | 206,427 | 128,546 |
| Operating Income | 141,445 | -103,279 | -130,624 | -127,171 | 1,468 |
| Interest Expense | 20,676 | 20,777 | 6,984 | 6,567 | 6,722 |
| Other Income | 3,350 | 3,508 | 1,954 | 2,293 | 572 |
| Pre-tax Income | 124,119 | -120,548 | -135,654 | -131,445 | -4,682 |
| Income Tax | -6,014 | N/A | -12,661 | N/A | N/A |
| Net Income Continuous | 130,133 | -120,548 | -122,993 | -131,445 | -4,682 |
| Net Income | $130,133 | $-120,548 | $-122,993 | $-131,445 | $-4,682 |
| EPS Basic Total Ops | 1.23 | -1.14 | -1.17 | -1.27 | -0.05 |
| EPS Basic Continuous Ops | 1.23 | -1.14 | -1.17 | -1.27 | -0.05 |
| EPS Diluted Total Ops | 1.16 | -1.14 | -1.17 | -1.27 | -0.05 |
| EPS Diluted Continuous Ops | 1.11 | -1.14 | -1.17 | -1.27 | -0.05 |
| EPS Diluted Before Non-Recurring Items | 1.35 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $146,564 | $-98,260 | $-126,626 | $-124,588 | $2,715 |